The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 randomized placebo-controlled trial of donepezil for late cancer-related cognitive impairment in breast cancer survivors exposed to chemotherapy from the Wake Forest NCORP Research Base REMEMBER trial (WF97116).
 
Steve R. Rapp
No Relationships to Disclose
 
Emily Van Meter Dressler
Research Funding - Omada Health
Other Relationship - ICF
(OPTIONAL) Uncompensated Relationships - Society for Clinical Trials
 
W. Mark Brown
No Relationships to Disclose
 
James Lloyd Wade
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Abbott (I); Bristol Myers Squibb (I); GlaxoSmithKline (I); Johnson & Johnson (I); Novartis (I)
Consulting or Advisory Role - New Century Health
 
Nguyet Le-Lindqwister
No Relationships to Disclose
 
David M. King
No Relationships to Disclose
 
Kendrith M. Rowland
No Relationships to Disclose
 
Kathryn E. Weaver
No Relationships to Disclose
 
Heidi D. Klepin
Patents, Royalties, Other Intellectual Property - UptoDate contributor
 
Edward G. Shaw
Stock and Other Ownership Interests - Embodied Labs; Embodied Labs (I)
Patents, Royalties, Other Intellectual Property - Book royalties
 
Glenn Jay Lesser
Honoraria - SDP Oncology
Consulting or Advisory Role - Agios; Cancer Expert Now; IN8bio; Ono Pharmaceutical
Research Funding - cns pharmaceuticals; Denovo Biopharma; Global Coalition for Adaptive Research; Incyte; Novocure; Oblato
Other Relationship - ASCO; NCI